Answers are grounded in this paper and cite their sources.
This in vitro study evaluated the activities of vancomycin, LY333328, and teicoplanin alone and in combination with gentamicin, rifampin, and RP59500 against Staphylococcus aureus isolates with intermediate susceptibilities to vancomycin. Ampicillin-sulbactam and trovafloxacin were also evaluated. LY333328 and ampicillin-sulbactam resulted in bactericidal activity against all isolates. The combination of gentamicin with glycopeptides showed synergistic activity, while rifampin had no added benefit.
No takes yet. Share an insight, caveat, or question.
Hershberger et al. (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: